News and Insights

$ATAI is developing fast-acting, patent-protected psychedelic treatments for depression, with strong clinical results and billion-dollar M&A comps. Backed by Bitcoin and biotech tailwinds, it’s a high-upside asymmetric play.

The Figma IPO on July 31, 2025, marked a significant milestone in the tech IPO landscape - a 250% pop on day one, the type of shit that makes fund managers cream their pants.

You don’t hear much about Williams Companies sounds inherently boring, but maybe that’s exactly why it matters. This is the kind of company that doesn’t need to sell the dream, they’re already operating the core systems that make the dream possible.